These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8144441)
1. In-vivo and in-vitro study of the postantibiotic effect of meropenem. Martín Caminero MM; Fuentes Martinez F; Izquierdo Izquierdo J; Gómez-Lus Centelles ML; Prieto Prieto J J Antimicrob Chemother; 1993 Dec; 32(6):917-8. PubMed ID: 8144441 [No Abstract] [Full Text] [Related]
2. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo. Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859 [TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations. Bowker KE; Holt HA; Reeves DS; MacGowan AP J Antimicrob Chemother; 1996 Dec; 38(6):1055-60. PubMed ID: 9023653 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro study of several pharmacodynamic effects of meropenem. Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J Scand J Infect Dis; 1995; 27(5):469-74. PubMed ID: 8588137 [TBL] [Abstract][Full Text] [Related]
5. The postantibiotic effect of meropenem and imipenem on selected bacteria. Nadler HL; Pitkin DH; Sheikh W J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436 [TBL] [Abstract][Full Text] [Related]
8. The postantibiotic effect of imipenem. Manek N; Andrews JM; Wise R J Antimicrob Chemother; 1986 Nov; 18(5):641. PubMed ID: 3100488 [No Abstract] [Full Text] [Related]
9. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem. Odenholt-Tornqvist I J Antimicrob Chemother; 1993 Jun; 31(6):881-92. PubMed ID: 8360126 [TBL] [Abstract][Full Text] [Related]
10. Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes. Herrera-Insúa I; Pérez P; Martínez P; Gómez-Lus ML; Prieto J J Antimicrob Chemother; 1997 Feb; 39(2):223-8. PubMed ID: 9069543 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans. Bowker KE; Holt HA; Lewis RJ; Reeves DS; MacGowan AP J Antimicrob Chemother; 1998 Oct; 42(4):461-7. PubMed ID: 9818744 [TBL] [Abstract][Full Text] [Related]
12. Postantibiotic effects of E-4868 and OPC-17116. Sanford MD; Jones RN J Antimicrob Chemother; 1993 Dec; 32(6):916-7. PubMed ID: 8144440 [No Abstract] [Full Text] [Related]
13. [Evaluation of the sensitivity to meropenem of some bacterial strains with nosocomial potential]. Dan L; Licker M; Grecu D; Dumitraşcu V; Branea D; Berceanu-Văduva D; Crăciunescu M; Iancu A; Orb C; Holoşpin M; Hogea E; Muntean D; Moldovan R Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):107-12. PubMed ID: 15341323 [TBL] [Abstract][Full Text] [Related]
14. Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics. Nussbaumer-Pröll AK; Knotzer S; Eberl S; Reiter B; Stimpfl T; Jäger W; Poschner S; Zeitlinger M Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):485-495. PubMed ID: 30687870 [TBL] [Abstract][Full Text] [Related]
15. The growth of bacteria in intravenous glyceryl trinitrate and in sodium nitroprusside. Bátai I; Kerényi M; Tekeres M Anesth Analg; 1999 Dec; 89(6):1570-2. PubMed ID: 10589651 [No Abstract] [Full Text] [Related]
16. Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens. Landini G; Di Maggio T; Sergio F; Docquier JD; Rossolini GM; Pallecchi L Antimicrob Agents Chemother; 2016 Dec; 60(12):7513-7517. PubMed ID: 27736757 [TBL] [Abstract][Full Text] [Related]
17. The antibacterial activity of meropenem in combination with gentamicin or vancomycin. Wise R; Ashby JP; Andrews JM J Antimicrob Chemother; 1989 Sep; 24 Suppl A():233-8. PubMed ID: 2509417 [TBL] [Abstract][Full Text] [Related]
18. Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli. Bergen PJ; Bulitta JB; Sime FB; Lipman J; McGregor MJ; Millen N; Paterson DL; Kirkpatrick CMJ; Roberts JA; Landersdorfer CB Diagn Microbiol Infect Dis; 2018 May; 91(1):69-76. PubMed ID: 29395712 [TBL] [Abstract][Full Text] [Related]
19. Control-related effective regrowth time and post-antibiotic effect of meropenem on gram-negative bacteria studied by bioluminescence and viable counts. Hanberger H; Svensson E; Nilsson LE; Nilsson M J Antimicrob Chemother; 1995 May; 35(5):585-92. PubMed ID: 7592171 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic. Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]